SCHEMBL27362860

SCHEMBL27362860

Cc1ccc(N2CCN(CC3CCN(C)CC3)CC2)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.50
NPSR1 Q6W5P4 1/20 0.50
CACNA2D1 P54289 1/20 0.44
CACNA1B Q00975 1/20 0.44
CACNB1 Q02641 1/20 0.44
CACNA1C Q13936 1/20 0.44
KMT2A Q03164 3/20 0.43
MEN1 O00255 2/20 0.43
ALDH1A1 P00352 3/20 0.43
KDM4E B2RXH2 2/20 0.43
POLB P06746 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
HTR7 P34969 1/20 0.43
ESRRB O95718 1/20 0.42
ESRRG P62508 1/20 0.42
ADRB1 P08588 1/20 0.42
GAA P10253 1/20 0.42
ADRA2C P18825 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27364621 0.97 MAPT (0.47) MAPTNPSR1CACNA2D1CACNA1BCACNB1
SCHEMBL24834707 0.94 MAPT (0.47) MAPTNPSR1CACNA2D1CACNA1BCACNB1
SCHEMBL12082219 0.90 MAPT (0.51) MAPTNPSR1KMT2AMEN1HTR7
SCHEMBL27364407 0.87 EBP (0.44) MAPTNPSR1CACNA2D1CACNA1BCACNB1
SCHEMBL22542091 0.87 MAPT (0.51) MAPTNPSR1KMT2AMEN1ALDH1A1
SCHEMBL3666881 0.86 SLC6A2 (0.53) KMT2AKDM4EHTR7GAADRD2
SCHEMBL27364131 0.86 DRD3 (0.43) MAPTCACNA2D1CACNA1BCACNB1CACNA1C
SCHEMBL20372819 0.86 MAPT (0.51) MAPTNPSR1ALDH1A1POLBHTR7
SCHEMBL15499062 0.84 MAPT (0.47) MAPTNPSR1KMT2AMEN1HTR7
SCHEMBL3665444 0.84 DRD2 (0.60) KMT2AMEN1DRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024054591-A1 RAPIDLY ACCELERATED FIBROSARCOMA (RAF) DEGRADING COMPOUNDS AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS, INC. (US) 2024-03-14 WO disclosed